Clin2
NCT07718581Possibly a fitRecruiting

New drug for advanced solid tumors

Solid Tumor, Adult

Part of Cancer clinical trials.

This study tests a new drug for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, helps shrink tumors, and improves quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
147 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have a solid tumor that has spread or cannot be removed.
  • You need to have at least one tumor that can be measured on a scan.
  • You should be able to take care of yourself (fully active or able to do light work).
  • You must not have had major surgery in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07396584Recruiting· Phase 1/Phase 2
HMPL-A580 for advanced or metastatic solid tumors

This trial tests a new drug called HMPL-A580 in people with advanced or metastatic solid tumors that cannot be removed by surgery. The goal is to see if it is safe and effective.

Orange, California
NCT07228247Recruiting· Phase 1/Phase 2
Study of a new drug for HER2-positive advanced solid tumors

This trial tests an investigational drug for people with advanced or metastatic HER2-positive solid tumors. The drug is designed to target cancer cells with HER2 and may slow tumor growth.

Denver, Colorado
NCT04998422Recruiting· Phase 1
First-time drug study for advanced solid tumors

This Phase 1 trial tests a new medicine (HG381) in people with advanced solid tumors to see how safe it is and how it works in the body. It may help if standard treatments have already stopped working or aren’t possible for you.

Chengdu, Sichuan
NCT04643418Recruiting· Phase 1/Phase 2
Study drug for advanced solid tumors you can’t remove

This trial tests MPB-1734, a new study drug, in adults with advanced solid tumors that can’t be removed and for which standard treatment has stopped working. It aims to find out how safe it is and whether it can shrink or control the cancer.

Taipei
NCT06825494Recruiting· Phase 1/Phase 2
Study of a new drug for advanced solid tumors

This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.

Hefei, Anhui
NCT07102004Recruiting· Phase 1/Phase 2
Testing a new drug for advanced solid tumors

This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.

Beijing

Hear when a new Solid Tumor, Adult trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.